Tormentic acid in foods exerts anti-proliferation efficacy through inducing apoptosis and cell cycle arrest

被引:28
作者
Zhang, Tian-Tian [1 ]
Yang, Li [1 ]
Jiang, Jian-Guo [1 ]
机构
[1] S China Univ Technol, Coll Food & Bioengn, Guangzhou 510640, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Tormentic acid; MCF-7; cell; Apoptosis; G0/G1; arrest; ROS; RUBUS-CHINGII HU; NF-KAPPA-B; PROSTATE-CANCER; IN-VITRO; FRUITS; DERIVATIVES; ACTIVATION; EXPRESSION; INDUCTION; PATHWAYS;
D O I
10.1016/j.jff.2015.09.061
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Tormentic acid (TA) is a triterpenoid saponin widely distributed in natural plant foods with various bioactivities. However, the underlying pathways through which TA exerts the bioactivities remain unclear. Here, experiments were carried out to elucidate the molecular mechanisms accounting for the antiproliferation of TA using MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide) assay, flow cytometry, quantitative real-time polymerase chain reaction and Western blotting analysis. TA exhibited a dose-dependent inhibitory effect on MCF-7 cells, which was caused by apoptosis and G0/G1 phase arrest. Reactive oxygen species (ROS) acts as an upstream mediator in TA-induced MCF-7 cell growth inhibition and intracellular ROS levels induced mitochondrial dysfunction, thereby resulting in the release of apoptogenic factors into cytosol, and then activating caspase-3 and caspase-9. TA induced cell cycle arrest via changing the cyclin D1 and cyclin-dependent kinase 4 messenger ribonucleic acid expression levels. Moreover, TA significantly down-regulated the NF-kappa-B cell survival pathway and the expression level of phosphorylated ERK. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:575 / 583
页数:9
相关论文
共 42 条
[1]   Tormentic acid, a triterpenoid saponin, isolated from Rosa rugosa, inhibited LPS-induced iNOS, COX-2, and TNF-α expression through inactivation of the nuclear factor-κb pathway in RAW 264.7 macrophages [J].
An, Hyo-Jin ;
Kim, In-Tae ;
Park, Hee-Juhn ;
Kim, Hyung-Min ;
Choi, Jung-Hye ;
Lee, Kyung-Tae .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (04) :504-510
[2]   Molecularly targeted therapies for metastatic triple-negative breast cancer [J].
Bayraktar, Soley ;
Glueck, Stefan .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (01) :21-35
[3]   The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells [J].
Carlisi, Daniela ;
Lauricella, Marianna ;
D'Anneo, Antonella ;
Buttitta, Giuseppina ;
Emanuele, Sonia ;
Di Fiore, Riccardo ;
Martinez, Roberta ;
Rolfo, Christian ;
Vento, Renza ;
Tesoriere, Giovanni .
JOURNAL OF CELLULAR PHYSIOLOGY, 2015, 230 (06) :1276-1289
[4]   Anti-inflammatory activities of tormentic acid from suspension cells of Eriobotrya Japonica ex vivo and in vivo [J].
Chang, Chwen-Tzuei ;
Huang, Shyh-Shyun ;
Lin, Shiang-Shiou ;
Amagaya, Sakae ;
Ho, Hui-Ya ;
Hou, Wen-Chi ;
Shie, Pei-Hsin ;
Wu, Jin-Bin ;
Huang, Guan-Jhong .
FOOD CHEMISTRY, 2011, 127 (03) :1131-1137
[5]   Tormentic acid derivatives: Synthesis and apoptotic activity [J].
Csuk, Rene ;
Siewert, Bianka ;
Dressel, Christian ;
Schaefer, Renate .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 56 :237-245
[6]   IMPACT OF HYPOXIA ON THE METASTATIC POTENTIAL OF HUMAN PROSTATE CANCER CELLS [J].
Dai, Yao ;
Bae, Kyungmi ;
Siemann, Dietmar W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02) :521-528
[7]   Antineoplastic impact of leishmanial sphingolipid in tumour growth with regulation of angiogenic event and inflammatory response [J].
Das, Subhadip ;
Chatterjee, Nabanita ;
Bose, Dipayan ;
Banerjee, Somenath ;
Jha, Tarun ;
Das Saha, Krishna .
APOPTOSIS, 2015, 20 (06) :869-882
[8]   The MAPK pathway in melanoma [J].
Fecher, Leslie A. ;
Arnaravadi, Ravi K. ;
Flaherty, Keith T. .
CURRENT OPINION IN ONCOLOGY, 2008, 20 (02) :183-189
[9]   Tormentic acid reduces vascular smooth muscle cell proliferation and survival [J].
Fogo, Anelize S. ;
Antonioli, Eliane ;
Calixto, Joao B. ;
Campos, Alexandre H. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 615 (1-3) :50-54
[10]   Targeting apoptosis pathways in cancer therapy [J].
Ghobrial, IM ;
Witzig, TE ;
Adjei, AA .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (03) :178-194